Susan Sabo-Wagner, MSN, RN, OCN, of the American Oncology Network, expressed excitement toward networking, innovative discussions, and panels on patient advocacy at Patient-Centered Oncology Care® (PCOC) 2024.
Patient-Centered Oncology Care® (PCOC) 2024 will take place in Nashville, Tennessee, from September 12 to 13. The meeting will showcase experts in the oncology space with discussions surrounding recent innovations that target patient care to increase quality of life.
Susan Sabo-Wagner, MSN, RN, OCN, vice president of clinical innovation at the American Oncology Network, serves as cochair for PCOC this year. In this interview, she explains why she is looking forward to networking and the panels on patient advocacy.
This transcript has been lightly edited for clarity.
Transcript
What are you looking forward to most as cochair of PCOC this year?
The things that I'm most looking forward to is, number one, networking. I think PCOC really brings [together] quite a large group of very interesting people across the oncology spectrum. I love to get together to see everybody that comes to that. I think there's a lot of very interesting speakers this year, from the keynote to all of the different panels.
I was actually just taking a look at the agenda this morning, and I'm very interested in some of the innovation discussions and a lot of the specific discussions on that. Then I saw that there's a couple of prizes, so I think that's a really cool addition this year.
What panels or specific topics are you looking forward to being discussed at PCOC?
I think anything around patient-specific advocacy. There's a couple of different panels dedicated to the different aggregating organizations, and I think that's going to be very interesting to understand. And I think just kind of getting to know what everybody's doing in this space. There's been a lot of changes and reimbursement changes this year, so understanding how everyone is impacted and how they're making changes to face those.
Finding the Right Biomarker Is Key to the TIGIT Puzzle, Experts Say
May 12th 2025Data for SKYSCRAPER-01, involving the anti-TIGIT antibody tiragolumab, align with recent bad news for this once-promising therapeutic target. But investigators involved in TIGIT studies say the problem is finding the right biomarker.
Read More
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More